Skip to main content
NCBI home page
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1977;70(Suppl 8):7–12. doi: 10.1177/00359157770700S802

Cinnarizine in the Treatment of Peripheral Vascular Disease

Mechanisms Related to its Clinical Action

M B Emanuel, J A Will
PMCID: PMC1542787  PMID: 20919380

Full text

PDF
7

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allewijn F. T. The distribution of cinnarizine and its metabolites in the rat. Life Sci. 1968 Sep 1;7(17):989–994. doi: 10.1016/0024-3205(68)90106-9. [DOI] [PubMed] [Google Scholar]
  2. Barnes A. J., Locke P., Scudder P. R., Dormandy T. L., Dormandy J. A., Slack J. Is hyperviscosity a treatable component of diabetic microcirculatory disease? Lancet. 1977 Oct 15;2(8042):789–791. doi: 10.1016/s0140-6736(77)90724-3. [DOI] [PubMed] [Google Scholar]
  3. Dormandy J. A., Hoare E., Colley J., Arrowsmith D. E., Dormandy T. L. Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. Br Med J. 1973 Dec 8;4(5892):576–581. doi: 10.1136/bmj.4.5892.576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dormandy J. A., Hoare E., Khattab A. H., Arrowsmith D. E., Dormandy T. L. Prognostic significance of rheological and biochemical findings in patients with intermittent claudication. Br Med J. 1973 Dec 8;4(5892):581–583. doi: 10.1136/bmj.4.5892.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Elkeles A. Alpha-ray activity in the large human arteries. Nature. 1969 Feb 15;221(5181):662–664. doi: 10.1038/221662a0. [DOI] [PubMed] [Google Scholar]
  6. Errill E. W. Rheology of blood. Physiol Rev. 1969 Oct;49(4):863–888. doi: 10.1152/physrev.1969.49.4.863. [DOI] [PubMed] [Google Scholar]
  7. Godfraind T., Kaba A. Blockade or reversal of the contraction induced by calcium and adrenaline in depolarized arterial smooth muscle. Br J Pharmacol. 1969 Jul;36(3):549–560. doi: 10.1111/j.1476-5381.1969.tb08010.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Godfraind T., Kaba A., Rojas R. Proceedings: Inhibition by cinnarizine of calcium channels opening in depolarized smooth muscle. Br J Pharmacol. 1973 Sep;49(1):164P–165P. [PMC free article] [PubMed] [Google Scholar]
  9. Godfraind T., Morel N. An upper limit to the number of calcium channels in smooth muscle as estimated with cinnarizine. Eur J Pharmacol. 1977 Jan 21;41(2):245–246. doi: 10.1016/0014-2999(77)90219-9. [DOI] [PubMed] [Google Scholar]
  10. Goyle K. B., Dormandy J. A. Abnormal blood viscosity in Raynaud's phenomenon. Lancet. 1976 Jun 19;1(7973):1317–1318. doi: 10.1016/s0140-6736(76)92651-9. [DOI] [PubMed] [Google Scholar]
  11. PHILIPSZOON A. J. Influence of cinnarizine on the labyrinth and on vertigo. Clin Pharmacol Ther. 1962 Mar-Apr;3:184–190. doi: 10.1002/cpt196232184. [DOI] [PubMed] [Google Scholar]
  12. Put T. The therapeutic value of cinnarizine in cervico-brachial and ischial syndromes. Arzneimittelforschung. 1969 Nov;19(11):1868–1869. [PubMed] [Google Scholar]
  13. Rosenblum W. I. "Viscosity-plus" effect in whole blood at high shear rates. Nature. 1969 Jan 25;221(5178):365–366. doi: 10.1038/221365a0. [DOI] [PubMed] [Google Scholar]
  14. Ross R., Glomset J. A. The pathogenesis of atherosclerosis (first of two parts). N Engl J Med. 1976 Aug 12;295(7):369–377. doi: 10.1056/NEJM197608122950707. [DOI] [PubMed] [Google Scholar]
  15. Schmitt G., Skrobek R., Hauss W. H. Uber die Wirkung von Cinnarizin (Stutgeron) auf die hochdruckbedingte Zellproliferation in Herz und Aorta im Tierexperiment. Med Welt. 1974 Jun 14;25(24):1096–1099. [PubMed] [Google Scholar]
  16. Schuermans V., Boermans A., Geivers H., Jageneau A., Brugmans J. Cinnarizine in peripheral vascular insufficiency. Studies on blood flow, muscle capacity, and vascular tone. Arzneimittelforschung. 1971 Oct;21(10):1541–1543. [PubMed] [Google Scholar]
  17. Soudijn W., Van Wijngaarden I. The metabolism and excretion of cinnarizine by rats. Life Sci. 1968 Mar 1;7(5):231–238. doi: 10.1016/0024-3205(68)90196-3. [DOI] [PubMed] [Google Scholar]
  18. TRUMBULL R., CHINN H. I., MAAG C. H., MILCH L. J., HANDFORD S. W., SEIBERT R., SPERLING P., SMITH P. K. Effect of certain drugs on the incidence of seasickness. Clin Pharmacol Ther. 1960 May-Jun;1:280–283. doi: 10.1002/cpt196013280. [DOI] [PubMed] [Google Scholar]
  19. Van Nueten J. M., Janssen P. A. Effect of cinnarizine on peripheral circulation in dogs. Eur J Pharmacol. 1972 Jan;17(1):103–106. doi: 10.1016/0014-2999(72)90275-0. [DOI] [PubMed] [Google Scholar]
  20. Verhaegen H., Roels V., Adriaensen H., Brugmans J., De Cock W., Dony J., Jageneau A., Schuermans V. The arteriolar effects of cinnarizine and flunarizine. Multitechnical investigations in normal volunteers and in patients with occlusive disease of the extremities secondary to arteriosclerosis. Angiology. 1974 Apr;25(4):261–278. doi: 10.1177/000331977402500405. [DOI] [PubMed] [Google Scholar]
  21. Weed R. I., Bowdler A. J. Metabolic dependence of the critical hemolytic volume of human erythrocytes: relationship to osmotic fragility and autohemolysis in hereditary spherocytosis and normal red cells. J Clin Invest. 1966 Jul;45(7):1137–1149. doi: 10.1172/JCI105420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Weed R. I., LaCelle P. L., Merrill E. W. Metabolic dependence of red cell deformability. J Clin Invest. 1969 May;48(5):795–809. doi: 10.1172/JCI106038. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES